Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity
The identification of effective new therapies for prostate cancer (PCa) requires a better understanding of the multiple molecular interactions between tumor cells and their associated microenvironment. In this context, galectin-1 (Gal-1) is a key molecule in the determination of the prostatic carcin...
Guardado en:
| Autores principales: | Corapi, E., Carrizo, G., Compagno, D., Laderach, D. |
|---|---|
| Formato: | JOUR |
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/20.500.12110/paper_16643224_v9_n_p2190_Corapi |
| Aporte de: |
Ejemplares similares
-
Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity
Publicado: (2018) -
Glycans and galectins in prostate cancer biology, angiogenesis and metastasis
por: Compagno, D., et al. -
Delineating the "galectin signature" of the tumor microenvironment
por: Compagno, D., et al. -
Glycans and galectins in prostate cancer biology, angiogenesis and metastasis
Publicado: (2014) -
A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease
por: Laderach, D.J., et al.